Informational Only · Not Legal Advice · Not a Law Firm · Editorial Policy

Hair Relaxer Lawsuit Settlement Payouts Explained for November Claimants

There is no hair-relaxer settlement payout waiting for November claimants. No global settlement, payout fund, or average award exists, and no plaintiff has been paid through the federal litigation. The cases form a mass tort, meaning many individual injury lawsuits handled together but decided on their own facts.

Miller & Zois reports no payout program exists as of November 2026 in its Miller & Zois lawsuit guide. The federal cases are consolidated as MDL No. 3060 before Judge Mary M. Rowland in the Northern District of Illinois.

Table of Contents

Where do the federal cases stand?

The consolidation covers federal hair-relaxer marketing and injury claims in one court for pretrial work. Central handling avoids duplicate discovery and conflicting rulings. Each plaintiff still must prove use, injury, and causation.

The docket keeps growing. The count reached 12,743 pending actions and 17,018 total filings on November 2, 2026. Growth at this stage is normal before bellwether picks and major rulings.

Why is there no payout date?

No settlement talks can set values before the court tests key proof and trial risks. Both sides are still fighting over experts, evidence, and which cases should go first. That work sets the price of later resolution. The schedule points to 2027 for the first major test.

The first federal bellwether trial is set for September 7, 2027, with expert discovery for the final five bellwether cases closing December 21, 2026 and summary-judgment motions due January 11, 2027, according to the MDL 3060 case tracker. On October 22, 2026, Judge Rowland kept the causation case alive by denying removal of general-causation expert Dr. Cote, with only a partial limit for expert Mr. Atwood.

📨 Get Free Mass Tort Guides Alerts

Free · No spam · Unsubscribe anytime

What do online dollar figures mean?

Published figures are attorney estimates, not court awards or settlement tiers. They reflect how firms value strong cases based on injury severity, care costs, and trial risk. They do not promise any claimant a set amount.

One firm projects many strong uterine-cancer claims at $150,000 to $750,000. ConsumerShield estimates $120,000 to $150,000-plus, with higher values for severe cancers and death. Actual value would turn on diagnosis, age, treatment, lost income, and proof of frequent product use.

Which injuries are central to the claims?

Firms point to frequent, long-term relaxer use followed by uterine or endometrial cancer, ovarian cancer, or fibroids requiring hysterectomy. Use history matters because occasional or brief use is harder to link to disease. Medical records showing diagnosis, surgery, and treatment carry the most weight.

The science most often cited is a large federal study. Frequent straightener users were more than twice as likely to develop uterine cancer in an NIH Sister Study of 33,497 women followed almost 11 years, with risk by age 70 rising from 1.64% to 4.05%, as described in the NIH news release. That finding does not decide any single case. It helps explain why uterine and endometrial cancers lead current case screening.

What can November claimants do now?

There is no settlement claim form or fund to join yet. Filing now means starting or joining a lawsuit, not applying for a payout. A lawyer review can tell you whether your use and diagnosis fit current screening.

  • List relaxer brands, salon visits, and years of home use
  • Save boxes, receipts, photos, and salon records when you have them
  • Request pathology reports, surgery notes, and cancer treatment records
  • Write a short timeline linking first use, regular use, and diagnosis

You Might Also Like

Owed money from a settlement? Check what is open at OpenClassActions.com. Caring for someone with dementia? Find practical guides at HelpDementia.com. Working out a skin routine? Evidence-based answers at AcneAdvocate.com. Forgot the name of a movie? Identify it at FindThisMovie.com. Was your data exposed? Track active breaches at DataBreachRadar.com.

We use cookies to run this site, measure how it’s used, and show ads. Choose “Essentials only” to limit cookies to what the site needs to work. Privacy Policy.